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A B S T R A C T
Objectives: Eﬀects of daily caﬀeine consumption on open-ﬁeld behaviours, serum corticosterone and brain
antioxidant levels were investigated after six hours of total sleep-deprivation in prepubertal mice. We tested the
hypothesis that daily caﬀeine consumption may signiﬁcantly alter behaviour, stress and antioxidative response
of prepubertal mice to an acute episode of total sleep-deprivation.
Methods: Prepubertal Swiss mice of both sexes were assigned to two main groups of 120 each (subdivided into
6 groups of 10 each, based on sex), and administered vehicle or graded oral doses of caﬀeine (10, 20, 40, 80 and
120 mg/kg/day) for 14 days. On day 14, a main group was subjected to 6 h of total sleep-deprivation by ‘gentle-
handling’. Open-ﬁeld behaviours were then assessed in both groups, after which animals were euthanized, and
levels of corticosterone, superoxide dismutase and glutathione peroxidase assayed.
Results: Horizontal locomotion, rearing and grooming increased signiﬁcantly, compared to control, with sleep-
deprived (SD) mice showing stronger caﬀeine-driven responses at higher doses; and SD female mice showing
sustained response to caﬀeine, compared to respective males. Plasma corticosterone increased with increasing
doses of caﬀeine in both non sleep-deprived (NSD) and SD mice; although SD mice had higher corticosterone
levels. Sleep-deprivation and/or higher doses of caﬀeine were associated with derangements in brain
antioxidant levels.
Conclusion: Repeated caﬀeine consumption and/or acute sleep-deprivation led to signiﬁcant changes in
pattern of open-ﬁeld behaviour and stress/antioxidant response in mice. Responses seen in the study are
probably due to modulatory eﬀects of caﬀeine on the total body response to stressful stimuli.
1. Introduction
Caﬀeine is a central nervous system stimulator that belongs to the
class of molecules known as xanthines [1,2]. Caﬀeine is found in tea,
coﬀee, mate, guarana paste and kola nuts, and it is consumed globally,
irrespective of age or social status [3]. In humans, studies continue to
shed light on the behavioural eﬀects of caﬀeine [4,5], especially in
adults; however, there is also a noticeable increase in the consumption
of caﬀeine and caﬀeine-containing products by children and adoles-
cents [6–9]. Studies have also been conducted to evaluate caﬀeine
safety in the young [6,7], and to determine dose/consumer-dependent
inﬂuences of caﬀeine use on the heart, blood-pressure and general
body physiology in children [8,9]; however, in comparison to adults,
data on caﬀeine research in the young is still less available.
A major reason for deliberate caﬀeine consumption is to combat
sleepiness. Sleepiness is deﬁned as diﬃculty in maintaining alertness
during the major wake period of the day, resulting in unintended lapses
into drowsiness or sleep [10]. Sleepiness is a known consequence of
sleep-deprivation in healthy humans; however, the quantity of sleep
needed by children, adolescents and young adults is still debated
[11,12]. Recent literature reveal that about 7–9 h of sleep is adequate
in young adults (18−25), 8–10 h in teenagers and 9–11 h in school
aged children (6−13) [13]. It is also reported that sleep-deﬁcits are
higher in adolescents compared to other age-groups, with females
showing greater need for sleep than males [14]. A number of human
studies have reported no diﬀerence in total sleep time all through the
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adolescence period on non-school days, and signiﬁcant loss of total
sleep time only during school days [15,16], suggesting psychosocial
factors as a sleep-time determinant in adolescents [17]. Sleep loss, and
poor quality of sleep have been associated with alterations in emotional
behaviour and decreased quality of life in young adults [18], and now
studies are beginning to show evidence of increasing caﬀeine con-
sumption in adolescents, to help cope with sleep loss [19]. Therefore, in
this group, cycles of caﬀeine consumption and insuﬃcient sleep tend to
succeed each other.
The existence of sex diﬀerences in the response to caﬀeine in young
subjects have been studied in humans [8,20] and rodents [21–23], with
diﬀerent conclusions. Soellner et al. [24] reported improved object-
discrimination in female rats, following caﬀeine ingestion. Elkins et al.
[20], looking at eﬀects of caﬀeine in prepubertal boys, concluded that
memory-impairment associated with caﬀeine in males was due to
increased vigilance and decreased reaction-time with caﬀeine at lower
doses. Fischer and Guillet [25] reported sex-diﬀerences in caﬀeine
eﬀect on memory retention in neonatal rats; however Temple et al., [8]
reported no sex-diﬀerences in cardiovascular response to caﬀeine in
adolescent boys or girls. The diﬀerences in the results of these studies
would suggest that in the outcomes of tasks involving caﬀeine admin-
istration, the inﬂuences of sex are probably task-speciﬁc. Sex-diﬀer-
ences in drug self-administration was ruled out in the present study, by
giving caﬀeine through gavage; since studies have reported that female
rodents are more vulnerable to stimulant self administration [26,27] or
drug seeking behaviour [28].
There is a dearth of information on the inﬂuence of sex on eﬀects of
caﬀeine on open- ﬁeld behaviours in rodents or motor activity in
humans; and where available, results of studies vary. Uzbay et al. [23]
reported the absence of sex-diﬀerences with caﬀeine administration in
mice, although a sex-diﬀerential response was seen with agmatine on
caﬀeine-induced locomotor response. In an earlier study [21], we
reported that male mice (more than females) showed an early
locomotor response, although females showed higher basal levels of
locomotion. However, the present study diﬀers from our previous study
in a few areas: age of animals used, doses of caﬀeine used and presence
of sleep-deprivation.
Sleep-deprivation by gentle-handling is a stressor, and has been
shown to be associated with elevated corticosterone [29] and altera-
tions in antioxidant activity [30,31]. Oxidative stress occurs due to an
imbalance between the production of oxidants and the strength of
antioxidant defences. These imbalances can cause structural changes
due to oxidation of proteins, lipids, and nucleic acids [32]. A number of
studies have reported evidence of oxidative stress following acute or
chronic sleep-deprivation [31–34]. An overall eﬀect of sleep-depriva-
tion on the body is a general sympathetic activation.
The rationale for this study was the need to answer the question:
can a history of caﬀeine consumption aﬀect behavioural phenotypes,
stress and antioxidant response, after a single episode of total sleep
deprivation? Therefore, we tested the hypothesis that background
caﬀeine consumption may signiﬁcantly alter novelty-induced beha-
viours, plasma corticosterone levels, superoxide dismutase and glu-
tathione peroxidase activity in prepubertal mice (with or without sleep
deprivation); and that these parameters could be inﬂuenced by sex.
2. Methods
2.1. Drugs
99.9% anhydrous caﬀeine (E. Merck, Darmstadt, Germany) was
weighed and dissolved in distilled water to get the desired concentra-
tions. Caﬀeine (10, 20, 40, 80 and 120 mg/kg) was administered orally
by using a cannula. The selection of these doses was based on a
previous study [22,35], although cognizance was also taken of the LD50
(oral) of caﬀeine in mice which is 127 mg/kg (male) and 137 mg/kg
(female) [36].
2.2. Animals
Five-week old Swiss mice (Empire Breeders, Osogbo, Osun State,
Nigeria) weighing 10–15 g at the commencement of study were used.
Male and female mice were housed separately in plastic cages measur-
ing 16×12×10 in. (10 mice in each cage). General housing is a
temperature-controlled (22.5 °C ± 2.5 °C) quarters with 12 h of light.
Mice had free access to food and water except during the behavioural
test. All animals were fed commercial standard chow (Calories: 29%
protein, 13% fat, 58% carbohydrate) from weaning. All procedures
were conducted in accordance with the approved institutional protocols
and within the provisions for animal care and use prescribed in the
scientiﬁc procedures on living animals, European Council Directive
(EU2010/63).
2.3. Experimental methods
Two main groups comprising one hundred and twenty mice each
were used (i.e. 120 males and 120 females). Each main group was
further subdivided into: Sleep deprived (SD) or non sleep-deprived
(NSD) of 60 each. Each subdivision has six sub-groups of 10 animals
each (Table 1); which received either vehicle (distilled water) or one of
ﬁve doses of caﬀeine (10, 20, 40, 80 and 120 mg/kg/day) for a period of
14 days. Tests were carried out after the last dose of caﬀeine or vehicle
in the NSD groups. Mice in the sleep-deprived groups (SD) were
subjected to six hours of gentle-handling after the last dose of vehicle or
caﬀeine, and then exposed to the behavioural tests. Immediately after
the behavioural tests, animals were euthanized and blood taken via
cardiac puncture for estimation of plasma corticosterone, while whole
brain homogenates were used for estimation of antioxidant levels.
2.3.1. Sleep-deprivation
Gentle-handling as a method of sleep-deprivation was ﬁrst used in
feline and rodents [37]. It has also been validated for use as a method
of total sleep-deprivation in mice [38]. It is a widely accepted as a way
to keep mice awake for periods of hours, while minimally disturbing
ongoing activity. Gentle-handling was the method of total sleep-
deprivation employed in this study. The gentle-handling protocol used
lasted for 6 h, starting at 7 a.m. It involved cage-shaking, touching the
animals with the hand or a soft brush, introducing novel objects into
the cage and cage-tapping.
2.3.2. Behavioural test
Behavioural tests were conducted in a quiet room between the
hours of 1 p.m and 3 p.m on day 14 of administration (5 animals/day).
On the test days, mice were transported in their home cages to the
testing room, and allowed to acclimatise for 30 min before testing. At
the beginning of the test, each mouse was placed in the open-ﬁeld box
and its behaviour videotaped for subsequent analysis. After testing, the
mouse was removed from the maze and all interior surfaces of the
open-ﬁeld box were cleaned thoroughly with 70% ethanol, and then
wiped dry to remove any trace of odour.
Table 1
Experimental groups, time-line and treatments administered.
Day 1–14 Day 14
Group/Treatment DW or Caffeine SD(6 h) or NSD Open-field (30 min)
Vehicle + + +
10 mg/kg + + +
20 mg/kg + + +
40 mg/kg + + +
80 mg/kg + + +
120 mg/kg + + +
Number of animals/group=10, Total number of animals/main group=120 (60 NSD,
60 SD), NSD: non sleep-deprived, SD: sleep-deprived, DW: distilled water
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2.3.2.1. Open ﬁeld novelty-induced behaviours. The open-ﬁeld test is
a complex behavioural paradigm whose components have been used
and accepted as measures of exploration and general activity or
locomotion [21,39,40] in rodents. The open-ﬁeld used in this study is
a wooden rectangular arena composed of a ﬂoor measuring
36×36×26 cm. The ﬂoor was divided by permanent red markings
into 16 equal squares at the bottom. It was placed in a sound-
isolated room with dim lighting. Locomotion (number of ﬂoor units
entered with all paws), rearing frequency (number of times the animal
stood on its hind legs or with its forearms against the walls of the
observation cage or free in the air) and frequency of grooming (number
of body-cleaning with paws, picking of the body and pubis with the
mouth, and face-washing actions) were recorded for thirty minutes,
and scored. An increase in locomotion, rearing and grooming connotes
a central excitatory response, while a decrease connotes central
inhibition.
2.3.3. Biochemical assay
2.3.3.1. Corticosterone assay. Plasma corticosterone (CORT) levels in
NSD/SD mice were analysed using commercially-available
corticosterone ELISA assay kit, which is a competitive enzyme
immunoassay for the quantitative measurement of corticosterone.
Standard or samples were added in duplicate to wells of the micro-
titre plate. Corticosterone conjugate and corticosterone antibody were
added to each well and allowed to incubate for 2 h at room
temperature. Unbound enzyme was washed. Streptavidin-peroxidase
conjugate was added to the wells and incubated for 30 min, following
which plates were washed again and chromogen substrate was added to
each well and allowed to incubate for about 20 min. Stop solution was
then added and absorbance read immediately at 450 nm. The
concentration of corticosterone was calculated according to the
standard curves.
2.3.3.2. Brain antioxidant assay. The whole brain was removed and
homogenized (1:10, w/v) in ice-cold phosphate-buﬀered saline using
Teﬂon-glass homogenizer. Homogenate was centrifuged at 10,000 rpm
at 4 °C for 15 min to remove cell debris. Superoxide dismutase level
was assayed (using a UV–vis spectrophotometer) based on the
enzyme's ability to inhibit phenazine methosulphate-mediated
reduction of nitro-blue tetrazolium dye; the change in absorbance at
560 nm over 5 min was measured. Glutathione peroxidase (GPX)
catalyzes the reduction of hydroperoxides (like hydrogen peroxide),
by reduced glutathione (GSH) and functions to protect the cell from
oxidative damage. GPX levels measure the change in absorbance at
340 nm that follow NADPH consumption in the presence of H2O2,
according to the manufacturer's instruction.
2.4. Statistical analysis
Data were analysed using Chris Rorden's ezANOVA for windows,
version 0.98. We tested the hypothesis that background caﬀeine
consumption may signiﬁcantly alter novelty-induced behaviours, plas-
ma corticosterone levels, superoxide dismutase and glutathione perox-
idase activity in prepubertal mice (with or without sleep deprivation);
and that the responses may be modulated by sex, using analysis of
variance (ANOVA). Multi-factorial ANOVA was used to test eﬀects of 3
main factors (dose of caﬀeine, sex and sleep-deprivation) on locomo-
tion, rearing, grooming, plasma corticosterone, and brain antioxidant
levels. Tukey HSD test was used for within and between-group
comparisons. Results are expressed as mean ± (S.E.M), p values less
than 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Horizontal locomotion
Fig. 1 shows eﬀect of increasing doses of caﬀeine on horizontal
locomotion in sleep-deprived (SD) and non sleep-deprived (NSD) male/
female mice. MANOVA with drug dose, sex and sleep deprivation as
main factors revealed a signiﬁcant eﬀect of drug dose {F(5,120) = 119, p
< 0.001} and sex {F(1,120) = 6.94, p < 0.011}, with no signiﬁcant eﬀect
of sleep-deprivation {F(1,120) = 1.68, p < 0.421}. There was however
signiﬁcant interactions between drug dosage×sex {F(5,120) = 9.32,
p < 0.001}, drug dosage×sleep-deprivation {F(5,120) = 27.0,
p < 0.001}, sex×sleep-deprivation {F(1,120) = 8.82, p < 0.003} and drug
dosage×sex ×sleep-deprivation {F(5,120) = 14.2, p < 0.001}.
Pairwise comparisons of the eﬀect of caﬀeine and vehicle revealed a
signiﬁcant (p < 0.001) increase in locomotor activity with caﬀeine at 10
(p < 0.001, p < 0.001), 20 (p < 0.001, p < 0.001), 40 (p < 0.001, p <
0.001), 80 (p < 0.001, p < 0.001) and 120 (p < 0.001, p < 0.001) in NSD
and SD female mice respectively, compared to either NSD or SD
vehicle. In male mice, there was a signiﬁcant increase in locomotor
activity with caﬀeine at 10 (p < 0.002), 20 (p < 0.001), 80 (p < 0.001)
and 120 mg/kg (p < 0.001) in NSD male mice compared to NSD
vehicle, and a signiﬁcant increase with caﬀeine at 10 (p < 0.001), 20
(p < 0.001), 40 (p < 0.001), 80 (p < 0.001) and 120 mg/kg (p < 0.001)
in SD male mice compared to SD vehicle.
Comparisons between NSD and SD (female/male mice) revealed no
signiﬁcant diﬀerence in locomotor activity between SD and NSD
female/male mice administered vehicle. With caﬀeine administration,
there was a signiﬁcant decrease in locomotor activity at 20 mg/kg (p <
0.030), and a signiﬁcant increase at 40 (p < 0.025), 80 (p < 0.001) and
120 mg/kg (p < 0.016) in SD compared to NSD female mice; while in
male mice, locomotor activity decreased signiﬁcantly at 10 (p < 0.001)
and 20 mg/kg (p < 0.041), and increased at 40 (p < 0.001) and 80 mg/
kg (p < 0.024) in SD compared to NSD male mice.
Comparisons between female and male (NSD/SD) mice revealed no
signiﬁcant diﬀerence in locomotor activity between NSD/SD female
and male mice administered vehicle. Caﬀeine administration resulted
in a signiﬁcant increase in locomotor activity at 40 (p < 0.009), and a
signiﬁcant decrease at 80 (p < 0.001) and 120 mg/kg (p < 0.001) in
NSD female compared to NSD male mice. With sleep-deprivation,
locomotor activity increased signiﬁcantly at 10 (p < 0.001), 20 (p <
0.001) and 120 mg/kg (p < 0.011), and decreased at 40 (p < 0.001) and
80 mg/kg (p < 0.046) in SD female compared to SD male mice.
Fig. 1. Eﬀect of Caﬀeine on horizontal locomotion in NSD/SD female and male mice.
Each bar represents mean ± SE.M. Comparisons are: *p < 0.05 versus VEH, #p < 0.05 SD
versus NSD mice, µp < 0.05 female versus male. VEH: Vehicle, SD: sleep deprived, NSD:
non sleep deprived, mg/kg, p.o: milligram/kilogram per oral, number of animals per
group-10.
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3.2. Rearing activity
Fig. 2 shows the eﬀect of increasing doses of caﬀeine on rearing in
NSD/SD male and female mice. MANOVA with drug dose, sex and
sleep-deprivation as main factors revealed a signiﬁcant eﬀect of drug
dose {F(5,120) = 27.8, p < 0.001} and sex {F(1,120) = 5.90, p < 0.017},
but no signiﬁcant eﬀect of sleep-deprivation {F(1,120) = 1.82, p <
0.254}. There was however signiﬁcant interactions between drug
dose×sleep-deprivation {F(5,120) = 4.23, p < 0.001} and sex×sleep-
deprivation {F(1,120) = 5.31, p < 0.022}; with no signiﬁcant interac-
tions between drug dose×sex {F(5,120) = 1.30, p < 0.185} or drug
dose×sex×sleep-deprivation {F(5,120) = 1.96, p < 0.324}.
Pairwise comparisons of the eﬀect of caﬀeine and vehicle, revealed a
signiﬁcant increase in rearing at 10 (p < 0.001), 20 (p < 0.001) and
40 mg/kg (p < 0.001); with a signiﬁcant decrease at 80 (p < 0.029) and
120 mg/kg (p < 0.016) in NSD female mice compared to NSD vehicle.
In NSD males, rearing activity increased with caﬀeine at 10 (p < 0.011),
20 (p < 0.033), 40 (p < 0.027) and 80 mg/kg (p < 0.011), and decreased
at 120 mg/kg (p < 0.020) compared to NSD vehicle. In both SD females
and SD males, rearing activity increased signiﬁcantly at 10 (p < 0.001,
p < 0.001), 20 (p < 0.001, p < 0.001), 40 (p < 0.001, p < 0.001) and
80 mg/kg (p < 0.005, p < 0.001) respectively compared to respective SD
female/male mice administered vehicle.
Comparisons between NSD and SD (female/male) mice revealed no
signiﬁcant diﬀerence in rearing activity between SD and NSD mice
administered vehicle. Caﬀeine administration resulted in signiﬁcant
increase in rearing activity at 40 (p < 0.012), 80 (p < 0.001) and
120 mg/kg (p < 0.011) in SD females compared to NSD females, and
a signiﬁcant decrease at 10 (p < 0.037) and 20 mg/kg (p < 0.020) in SD
males compared to NSD male mice.
Comparisons between female and male (NSD/SD) mice revealed no
signiﬁcant diﬀerence in rearing activity between NSD/SD female and
male mice administered vehicle. Caﬀeine administration resulted in a
signiﬁcant increase in rearing at 20 mg/kg (p < 0.019), and a decrease
at 80 (p < 0.001) and 120 mg/kg (p < 0.001) in NSD females compared
to NSD male mice; while a signiﬁcant increase in rearing was seen at 10
(p < 0.001), 20 (p < 0.001) and 80 mg/kg (p < 0.001) in SD female
compared to SD male mice.
3.3. Grooming Behaviour
Fig. 3 shows the eﬀect of increasing doses of caﬀeine on grooming
in NSD/SD male and female mice. MANOVA with drug dose, sex and
sleep-deprivation as main factors revealed a signiﬁcant eﬀect of sleep-
deprivation {F(1,120) = 8.26, p < 0.005} but no signiﬁcant eﬀect of
drug dose {F(5,120) = 1.12, p < 0.556} or sex {F(1,120) = 0.070, p <
0.315}. There were no signiﬁcant interactions between drug dose×-
sleep-deprivation {F(5,120) = 0.427, p < 0.153}, drug dose×sex
{F(5,120) = 0.083, p < 0.151}, sex×sleep-deprivation {F (1,120) =
0.127, p < 0.355} drug dose×sex×sleep-deprivation {F(5,120) =
0.081, p < 0.180}.
Pairwise comparisons of the eﬀect of caﬀeine and vehicle revealed a
signiﬁcant decrease in grooming at 10 mg/kg (p < 0.023), and an
increase at 20 (p < 0.001), 40 (p < 0.021) and 80 mg/kg (p < 0.001)
in NSD females compared to NSD vehicle. In SD female mice,
grooming increased at 10 (p < 0.034), 20(p < 0.011), 40 (p < 0.024)
and 80 mg/kg (p < 0.042), compared to SD vehicle. Grooming in-
creased signiﬁcantly at 10 (p < 0.040, p < 0.032), 20 (p < 0.001, p <
0.025), 40 (p < 0.011, p < 0.01) and 80 mg/kg (p < 0.021, p < 0.011) in
NSD and SD male mice respectively, compared to NSD/SD vehicle.
Comparisons between NSD and SD (female/male) mice revealed no
signiﬁcant diﬀerence in grooming between SD and NSD female/male
mice administered vehicle. Caﬀeine administration resulted in a
signiﬁcant increase in grooming in SD female mice at 10 (p < 0.001),
20 (p < 0.001) and 80 mg/kg (p < 0.001) compared to NSD females. In
male mice, there was no signiﬁcant diﬀerence in grooming in SD
compared to NSD groups.
Comparisons between female and male (NSD/SD) mice revealed no
signiﬁcant diﬀerence in grooming behaviour between NSD/SD female
and male mice administered vehicle. Caﬀeine administration resulted
in a signiﬁcant decrease in grooming at 10 (p < 0.011) and 80 mg/kg (p
< 0.041) in NSD females compared to NSD males, and no signiﬁcant
diﬀerence between SD female and SD male mice.
3.4. Plasma corticosterone assay
Table 2 shows the eﬀect of caﬀeine on plasma corticosterone levels
in NSD/SD male and female mice. MANOVA with drug dose, sex and
sleep-deprivation as main factors revealed a signiﬁcant eﬀect of drug
dose {F(5,120) = 21.5, p < 0.001}, sex {F(1,120) = 99.3, p < 0.002} and
sleep-deprivation {F(1,120) = 141, p < 0.001}. There were also sig-
niﬁcant interactions between drug dose×sex {F(5,120) = 3.40,
p < 0.007} and drug dose×sleep-deprivation {F(5,120) = 3.55,
p < 0.005}; and no signiﬁcant interactions between sex×sleep-depriva-
tion {F(1,120) = 0.06, p < 0.804} and drug dose×sex×sleep-deprivation
Fig. 2. Eﬀect of Caﬀeine on rearing in NSD/SD female and male mice. Each bar
represents mean ± SE.M. Comparisons are: *p < 0.05 versus VEH, #p < 0.05 SD versus
NSD mice, µp < 0.05 female versus male. VEH: Vehicle, SD: sleep deprived, NSD:
non sleep deprived, mg/kg, p.o: milligram/kilogram per oral, number of animals per
group-10.
Fig. 3. Eﬀect of Caﬀeine on rearing in NSD/SD female and male mice. Each bar
represents mean ± S.E.M. Comparisons are: *p < 0.05 versus VEH, #p < 0.05 SD versus
NSD mice, µp < 0.05 female versus male. VEH: Vehicle, SD: sleep deprived, NSD:
non sleep deprived, mg/kg, p.o: milligram/kilogram per oral, number of animals per
group-10.
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{F(5,120) = 1.82, p < 0.113}.
Pairwise comparisons of the eﬀect of caﬀeine and vehicle revealed a
signiﬁcant decrease in corticosterone levels at 10 mg/kg (p < 0.019),
and a signiﬁcant increase at 120 mg/kg (p < 0.005) in NSD females;
while in SD females, corticosterone levels increased at 80 (p < 0.032)
and 120 mg/kg (p < 0.005). In males, corticosterone levels increased
signiﬁcantly at 120 mg/kg (p < 0.011, p < 0.001) in both NSD and SD
groups compared to vehicle.
Comparisons between NSD and SD (female/male) mice revealed no
signiﬁcant diﬀerence in corticosterone levels between SD and NSD
female/male mice administered vehicle. Caﬀeine administration re-
sulted in a signiﬁcant increase in corticosterone levels at 10 (p < 0.001),
40 (p < 0.001), 80 (p < 0.005) and 120 mg/kg (p < 0.001) in SD females
compared to NSD female mice. A signiﬁcant increase is seen at 10 (p <
0.013), 20 (p < 0.002), 40 (p < 0.045), 80 (p < 0.006) and 120 mg/kg (p
< 0.001) in SD males compared to NSD male mice.
Comparisons between female and male (NSD/SD) mice revealed no
signiﬁcant diﬀerence in corticosterone levels between NSD/SD female
and male mice administered vehicle. Caﬀeine administration results in
a signiﬁcant increase in corticosterone levels in female NSD mice at 20
(p < 0.001), 40 (p < 0.013), 80 (p < 0.030) and 120 mg/kg (p < 0.001)
compared to male NSD mice. With sleep-deprivation, corticosterone
levels increased signiﬁcantly in SD females at 10 (p < 0.035), 40 (p <
0.001), 80 (p < 0.019) and 120 mg/kg (p < 0.045) compared to SD male
mice.
3.5. Brain antioxidant levels
Table 3 shows the eﬀect of increasing doses of caﬀeine on super-
oxide dismutase activity in NSD/SD male and female mice. MANOVA
with drug dose, sex and sleep-deprivation as main factors revealed a
signiﬁcant eﬀect of drug dose {F(5,120) = 26.6, p < 0.001}, sex
{F(1,120) = 4.52, p < 0.036}, and sleep-deprivation {F(1,120) = 7.64,
p < 0.007}, with no signiﬁcant interactions between drug dose×sex
{F(5,120) = 0.596, p < 0.703}, drug dose×sleep-deprivation {F(5,120)
= 0.411, p < 0.841}, sex×sleep-deprivation {F(1,120) = 0.152, p <
0.697} and drug dose×sex×sleep-deprivation {F(5,120) = 0.199, p <
0.902}.
Pairwise comparisons of the eﬀect of caﬀeine and vehicle revealed a
signiﬁcant increase in super-oxide dismutase (SOD) activity at 80 (p <
0.005) and 120 mg/kg (p < 0.002) in NSD females, and an increase at
40 (p < 0.015), 80 (p < 0.003) and 120 mg/kg (p < 0.001) in SD female
mice compared to vehicle. SOD activity increased signiﬁcantly at 40 (p
< 0.027, p < 0.041), 80 (p < 0.008, p < 0.05) and 120 mg/kg (p < 0.001,
p < 0.001) in NSD and SD males respectively compared to vehicle.
Comparisons between NSD and SD (female/male) mice revealed no
signiﬁcant diﬀerence in SOD activity between SD and NSD female/
male mice administered vehicle, or at any of the doses of caﬀeine.
Comparisons between female and male (NSD/SD) mice revealed no
signiﬁcant diﬀerence in SOD activity between NSD/SD female and
male mice administered vehicle or at any of the doses of caﬀeine.
Table 3 also shows the eﬀect of increasing doses of caﬀeine on
glutathione peroxidase activity in NSD/SD male and female mice.
MANOVA with drug dose, sex and sleep-deprivation as main factors
revealed a signiﬁcant eﬀect of drug dose {F(5,120) = 24.8, p < 0.001},
sex {F(1,120) = 3.38, p < 0.043}, and sleep-deprivation {F(1,120) =
8.63, p < 0.010}. There was no signiﬁcant interactions between drug
dose×sex {F(5,120) = 0.857, p < 0.512}, drug dose×sleep-deprivation
{F(5,120) = 0.784, p < 0.563}, sex×sleep-deprivation {F(1,120) =
0.760, p < 0.385} and drug dose×sex×sleep-deprivation {F(5,120) =
2.22, p < 0.056}.
Pairwise comparisons of the eﬀect of caﬀeine and vehicle revealed a
signiﬁcant decrease in glutathione peroxidase (GPX) activity at 80 (p <
0.001, p < 0.021) and 120 mg/kg (p < 0.023, p < 0.011) in NSD and SD
females respectively compared to NSD/SD vehicle; in males, GPX
activity also decreased signiﬁcantly at 80 (p < 0.013, p < 0.001) and
120 mg/kg (p < 0.002, p < 0.011) in NSD and SD males respectively
compared to NSD/SD vehicle.
Comparisons between NSD and SD (female/male) mice revealed no
signiﬁcant diﬀerence in GPX activity between SD and NSD female/
male mice administered vehicle, or at any of the doses of caﬀeine.
Comparisons between female and male (NSD/SD) mice revealed no
signiﬁcant diﬀerence in GPX activity between NSD/SD female and
male mice administered vehicle or at any of the doses of caﬀeine.
4. Discussion
This study set out to assess the interactions that exist among three
main factors (graded doses of caﬀeine, sex and sleep-deprivation) in
relation to novelty-induced behaviours, biochemical markers of stress
and antioxidant status in prepubertal mice. The overall ﬁnding was that
in the determination of open-ﬁeld behavioural response, strong
Table 2
Corticosterone (CORT) levels (ng/ml).
Female NSD Male NSD Female SD Male SD
VEH 116.5 ± 2.95 95.67 ± 5.69 128.5 ± 7.31 122.83 ± 2.78
10 105.5 ± 2.6* 93.67 ± 6.08 121.67 ± 2.99µ# 115.50 ± 2.54#
20 117.17 ± 1.95µ 97.00 ± 6.57 125.00 ± 2.59 114.17 ± 3.63#
40 118.17 ± 2.54µ 97.88 ± 8.25 147.50 ± 6.48µ# 120.83 ± 2.38#
80 122.17 ± 3.11µ 102.33 ± 3.31 160.17 ± 9.55*µ# 127.17 ± 2.98#
120 138.00 ± 5.13*µ 114.17 ± 3.63* 177.67 ± 5.30*µ# 140.33 ± 4.83*#
Mean ± S.E.M. Comparisons are: *p < 0.05 versus VEH, #p < 0.05 SD versus NSD mice,
µp < 0.05 male versus female. VEH: Vehicle, SD: sleep-deprived, NSD: non sleep-
deprived, number of animals per group-7.
Table 3
Superoxide dismutase and glutathione activity.
Female NSD Male NSD Female SD Male SD
SOD/U/g VEH 31.33 ±1.71 29.83 ±1.74 34.33 ± 1.76 33.50 ±1.78
10 31.17 ±1.30 33.17 ±1.74 35.00 ± 2.13 34.83 ±2.14
20 34.83 ±0.79 34.50 ±2.15 38.67 ± 1.65 37.00 ±1.57
40 37.67 ±2.33 37.33 ±2.30* 42.17 ± 2.01* 38.50 ±1.18*
80 43.00 ±2.79* 39.33 ±1.30* 41.33 ± 1.20* 44.33 ±1.94*
120 46.67 ±2.17* 46.33 ±1.82* 43.67 ± 2.04* 43.83 ±1.28*
GPX U/g VEH 5.50 ±0.34 5.59 ±0.26 4.80 ±0.31 4.75 ±0.49
10 4.67 ±0.48 4.73 ±0.59 4.22 ±0.99 4.20 ±0.35
20 4.39 ±0.37 4.46 ±0.38 4.14 ±0.33 4.10 ±0.25
40 4.27 ±0.21 4.28 ±0.42 4.08 ±0.39 4.00 ±0.57
80 2.67 ±0.43* 3.07 ±0.44* 2.00 ±0.28* 2.13 ±0.28*
120 1.93 ±0.22* 2.01 ±0.53* 1.81 ±0.19* 1.84 ±0.55*
Mean ± S.E.M. Comparisons are: *p < 0.05 versus VEH, VEH: Vehicle, SD: sleep-deprived, NSD: non sleep-deprived, number of animals per group-7.
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associations exist among these factors; while with respect to plasma
corticosterone levels and brain antioxidant activities, the associations
were not as strong. Sex and caﬀeine dose independently altered
locomotor activity and rearing. Sleep-deprivation did not signiﬁcantly
aﬀect locomotion, although it potentiated the eﬀects of caﬀeine dose
and sex. Assessment of grooming however showed that total sleep-
deprivation independently altered outcome, while sex and caﬀeine dose
did not exert any signiﬁcant main eﬀect. With the biochemical and
antioxidant tests, caﬀeine dose, sex and sleep-deprivation inﬂuenced
outcomes, each independent of the other; with no signiﬁcant interac-
tions among them.
Novelty-induced horizontal locomotion (Fig. 1) and rearing (Fig. 2)
showed a general locomotor-stimulating eﬀect of caﬀeine in both
females and males (with or without sleep-deprivation), when compared
to their respective vehicle groups. Horizontal locomotion and rearing
are well-documented measures of explorative ability; and as seen in our
study, caﬀeine administration (within the range of doses used) resulted
in a biphasic eﬀect on locomotion, with enhanced locomotor activity at
low doses and suppression at high doses; a result consistent with
several studies in adult rodents [41,42]. El Yacoubi et al. [41] also
reported a biphasic eﬀect of caﬀeine on locomotion of wild-type mice
not habituated to the open-ﬁeld, which is similar to the response seen
in NSD prepubertal mice in this study. The stimulatory eﬀect of
caﬀeine has been attributed to its eﬀects on adenosine receptors
[41,42]. Speciﬁcally, the stimulant eﬀect of low doses of caﬀeine is
known to be mediated by A2A receptor blockade [41]. Eﬀects of caﬀeine
on both horizontal locomotion and rearing in the present study,
supports the results of a number of other studies [41,43], and the
suggestions that these eﬀects are direct consequences of caﬀeine
antagonism at ventral and dorsal striatum adenosine A2A receptors
respectively [41]. However, the biphasic eﬀect of caﬀeine dose on
locomotion and rearing seen in NSD groups in this study is blunted by
acute sleep-deprivation (regardless of sex); we observed that in the SD
mice, excitatory eﬀects seem to persist to the higher doses.
In mice, spontaneous resting behaviour, humoral constitution and
synaptic function may all be aﬀected by sleep-deprivation. It is known
that repeated brief handling provokes a number of changes in both
mouse behaviour and physiological constitution and these changes are
known to persist for a number of days. There have been reports on the
eﬀects of sleep-deprivation on brain function [35,44–46] (with varying
results). Berro et al., [45] and Saito et al. [46] reported a potentiation of
the eﬀects of psycho-stimulants (cocaine and amphetamine) on loco-
motion in sleep-deprived mice, possibly through a synergism at
dopamine receptors. Onaolapo et al., [35], while studying the eﬀect
of sleep-deprivation and caﬀeine administration on memory, con-
cluded that caﬀeine/sleep-deprivation interactions resulted in varying
eﬀects on memory in adult mice. Sleep-deprivation inﬂuences the
dopaminergic system; causing increased density of both D1 and D2
dopaminergic receptors [47,48]. Studies have also shown that sleep-
deprivation induced alteration of locomotion and rearing are related
extensively to an increase in dopaminergic neurotransmission [49]. In
this study, following sleep-deprivation, we saw a blunting of the
expected biphasic eﬀect of caﬀeine on both locomotion and rearing,
with a potentiation of locomotion and rearing at higher doses of
caﬀeine in both sexes, although more consistently in females.
Grooming behaviour (Fig. 3) increased signiﬁcantly in both NSD
and SD mice across all doses relative to vehicle; although at some doses
(especially in females), SD mice showed a higher tendency to groom
compared to NSD. Grooming is an important aspect of the behavioural
repertoire in rodents, and it is exhibited as a complex hierarchy of
patterns that are sensitive to stress and drugs. Increase in grooming
seen in NSD animals could be due to increased anxiety that has been
associated with caﬀeine administration at doses similar to those used in
this study [50,51] while the signiﬁcant increase in grooming in SD mice
(compared to NSD) could be due to summation of both anxiety from
caﬀeine and stress response of sleep-deprivation. Studies have shown
that stress [52] and elevated stress hormones [53] induce grooming.
Activation of central dopaminergic (D1) [54] and/or inhibition of γ-
amino-butyric acid (GABA A and B) ergic receptors are also known to
induce intense grooming [55].
In this study, peak behavioural response following caﬀeine admin-
istration was higher in females compared to males (with both locomo-
tion and rearing), although no diﬀerence was seen with grooming.
Generally, the diﬀerences in response is more dose-related than sex-
speciﬁc; with signiﬁcant increase seen in females compared to males at
certain doses and decrease at other doses. This supports our observa-
tion from another study [22] in which we concluded that with respect
to prepubertal mice, caﬀeine's inﬂuence on another behavioural
response (memory) was both dose-speciﬁc and sex-related. Also, in
the present study, an increase in corticosteroid level was seen in
females compared to males, and this could be responsible for the
higher response to caﬀeine in SD female mice.
Studies have reported sleep-deprivation-dependent alterations in
glucocorticoid levels in rodents and humans [56,57]. In this study, we
saw a non-signiﬁcant increase in plasma corticosterone levels (Table 2)
with increasing doses of caﬀeine in the NSD groups, and a signiﬁcant
increase at the higher doses of caﬀeine in the SD groups. In a study
assessing the eﬀects of sleep-deprivation in neonatal rats, Hairston
et al., [57] reported an increase in corticosterone levels; a result similar
to what was seen in our study. NSD mice only showed minimal increase
in corticosterone levels, which suggest that sleep-deprivation in itself
elicits a stress response, the severity of which, is related to the length or
mode of sleep-deprivation. Sex diﬀerences in stress response have been
reported in a number of studies; in a study by Romeo et al., [58],
prepubertal male mice had higher levels of glucocorticoids compared to
adult males, although the female response was not age-dependent. In
this study, levels of corticosterone in females were higher than males in
both SD and NSD mice; the reasons for these diﬀerences in stress
response are still being examined.
In the present study, brain glutathione activity decreased, while brain
superoxide dismutase activity (Table 3) increased with increasing doses
of caﬀeine in both SD and NSD. However, no signiﬁcant eﬀect of sleep-
deprivation or sex inﬂuence was seen. Sleep-deprivation studies are based
on the premise that wakefulness represents an oxidative challenge for the
brain, which is controlled by sleep [59,60]. There are also suggestions
that during sleep, glutathione and uridine may aid brain oxidative
detoxiﬁcation by facilitating γ-amino butyric acid-related transmission
and inhibiting glutamatergic transmission [61]. However, in our study,
the results of comparisons between SD and NSD mice revealed no
signiﬁcant eﬀect of stress on antioxidant status. This supports the results
of a study by Noschang et al. [62] in which no diﬀerence in antioxidant
enzyme activity between stressed and non-stressed rats was observed. In
both SD and NSD mice, glutathione peroxidase activity decreased and
superoxide dismutase activity increased with increasing doses of caﬀeine
suggesting an imbalance in brain antioxidant status in prepubertal mice.
Studies have shown that caﬀeine has antioxidant properties [62–64];
linked to its ability to regulate reactive oxygen species via adenosine
receptors activation [65,66]. Also caﬀeine's ability to mop up peroxide
radicals [63] may be responsible for the slight increase in SOD activity
seen at low doses of caﬀeine in this study. However, studies have also
shown that the eﬀects of caﬀeine on antioxidant status are dose related;
with reports of increased oxidative stress with high doses of caﬀeine
[67,68]. The signiﬁcant increase in SOD activity and decrease in GPX
activity seen in this study (with increasing doses of caﬀeine) is suggestive
of oxidative stress.
5. Conclusion
A combination of caﬀeine and sleep-deprivation inﬂuences open-
ﬁeld behaviours, stress response and brain antioxidant status in
prepubertal mice; leading to the exhibition of a pattern of response
that is modulated by sex.
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